Analysts Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $63.67

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokers that have covered the stock in the last year is $63.67.

Several brokerages have recently commented on ASTH. Macquarie upgraded Astrana Health to a “hold” rating in a research report on Monday, December 16th. Truist Financial decreased their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Finally, Robert W. Baird lifted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th.

Astrana Health Stock Up 3.6 %

Shares of NASDAQ:ASTH opened at $38.04 on Wednesday. Astrana Health has a 52-week low of $29.08 and a 52-week high of $63.20. The firm has a fifty day moving average of $35.35 and a 200 day moving average of $45.61. The firm has a market capitalization of $2.14 billion, a PE ratio of 29.26, a price-to-earnings-growth ratio of 1.37 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Hedge Funds Weigh In On Astrana Health

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Astrana Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company’s stock worth $147,748,000 after purchasing an additional 20,757 shares during the last quarter. State Street Corp bought a new stake in shares of Astrana Health in the 3rd quarter worth approximately $91,966,000. Geode Capital Management LLC purchased a new position in shares of Astrana Health during the third quarter valued at approximately $58,995,000. FMR LLC bought a new position in shares of Astrana Health during the third quarter valued at approximately $48,413,000. Finally, SteelPeak Wealth LLC purchased a new stake in Astrana Health in the third quarter worth $39,398,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.